2-74462544-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_006302.3(MOGS):​c.1245C>G​(p.Ile415Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00284 in 1,610,242 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. I415I) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0098 ( 22 hom., cov: 33)
Exomes 𝑓: 0.0021 ( 16 hom. )

Consequence

MOGS
NM_006302.3 missense

Scores

2
15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0140

Publications

4 publications found
Variant links:
Genes affected
MOGS (HGNC:24862): (mannosyl-oligosaccharide glucosidase) This gene encodes the first enzyme in the N-linked oligosaccharide processing pathway. The enzyme cleaves the distal alpha-1,2-linked glucose residue from the Glc(3)-Man(9)-GlcNAc(2) oligosaccharide precursor. This protein is located in the lumen of the endoplasmic reticulum. Defects in this gene are a cause of type IIb congenital disorder of glycosylation (CDGIIb). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
MOGS Gene-Disease associations (from GenCC):
  • MOGS-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Orphanet, PanelApp Australia, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0016709566).
BP6
Variant 2-74462544-G-C is Benign according to our data. Variant chr2-74462544-G-C is described in ClinVar as Benign. ClinVar VariationId is 382459.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00978 (1490/152316) while in subpopulation AFR AF = 0.0318 (1322/41568). AF 95% confidence interval is 0.0304. There are 22 homozygotes in GnomAd4. There are 696 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 22 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MOGSNM_006302.3 linkc.1245C>G p.Ile415Met missense_variant Exon 4 of 4 ENST00000448666.7 NP_006293.2
MOGSNM_001146158.2 linkc.927C>G p.Ile309Met missense_variant Exon 5 of 5 NP_001139630.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MOGSENST00000448666.7 linkc.1245C>G p.Ile415Met missense_variant Exon 4 of 4 1 NM_006302.3 ENSP00000410992.3

Frequencies

GnomAD3 genomes
AF:
0.00973
AC:
1481
AN:
152198
Hom.:
22
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0317
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00327
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00311
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00123
Gnomad OTH
AF:
0.00574
GnomAD2 exomes
AF:
0.00342
AC:
849
AN:
247952
AF XY:
0.00304
show subpopulations
Gnomad AFR exome
AF:
0.0315
Gnomad AMR exome
AF:
0.00128
Gnomad ASJ exome
AF:
0.00336
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.0000467
Gnomad NFE exome
AF:
0.000872
Gnomad OTH exome
AF:
0.00282
GnomAD4 exome
AF:
0.00211
AC:
3078
AN:
1457926
Hom.:
16
Cov.:
31
AF XY:
0.00210
AC XY:
1524
AN XY:
724700
show subpopulations
African (AFR)
AF:
0.0312
AC:
1040
AN:
33324
American (AMR)
AF:
0.00133
AC:
59
AN:
44474
Ashkenazi Jewish (ASJ)
AF:
0.00263
AC:
68
AN:
25904
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39614
South Asian (SAS)
AF:
0.00558
AC:
481
AN:
86124
European-Finnish (FIN)
AF:
0.000263
AC:
14
AN:
53248
Middle Eastern (MID)
AF:
0.00696
AC:
40
AN:
5748
European-Non Finnish (NFE)
AF:
0.00106
AC:
1181
AN:
1109320
Other (OTH)
AF:
0.00316
AC:
190
AN:
60170
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
218
437
655
874
1092
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00978
AC:
1490
AN:
152316
Hom.:
22
Cov.:
33
AF XY:
0.00935
AC XY:
696
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.0318
AC:
1322
AN:
41568
American (AMR)
AF:
0.00327
AC:
50
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00123
AC:
84
AN:
68030
Other (OTH)
AF:
0.00568
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
69
138
206
275
344
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00151
Hom.:
3
Bravo
AF:
0.0109
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.0288
AC:
113
ESP6500EA
AF:
0.00145
AC:
12
ExAC
AF:
0.00397
AC:
480
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.00115
EpiControl
AF:
0.000771

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Apr 21, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

MOGS-congenital disorder of glycosylation Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
7.2
DANN
Benign
0.72
DEOGEN2
Benign
0.0036
T;T;.;.;.;.
Eigen
Benign
-0.97
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.0
.;T;.;T;T;T
MetaRNN
Benign
0.0017
T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.90
L;L;.;.;.;.
PhyloP100
-0.014
PrimateAI
Benign
0.29
T
PROVEAN
Benign
0.0
.;N;.;.;N;.
REVEL
Benign
0.020
Sift
Pathogenic
0.0
.;T;.;.;T;.
Sift4G
Pathogenic
0.0
.;T;.;.;T;.
Vest4
0.0
ClinPred
0.000024
T
GERP RS
1.7
Varity_R
0.050
gMVP
0.32
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34838944; hg19: chr2-74689671; API